Calcium Hydroxylapatite Safety at Four Years
Safety language around collagen stimulators is dense. This note reads one report on calcium hydroxylapatite and says what it asks of you, in short lines.
The document and who published it
The document is a report on a study of calcium hydroxylapatite, published at www.mdedge.com. A second piece from the same publisher is titled Don't Oversell the Results Achieved With Radiesse, and it is worth opening beside this one.
What the report says, and what to do with it
www.mdedge.com reports:
The calcium hydroxylapatite particles degrade over time to calcium particles and phosphate ions.
Directive: do not picture the material as permanent particles. The report says they break down.
The report also carries this statement about the material:
This material is highly biocompatible, it's durable, it does not migrate, it's not antigenic, and it's [radiopaque].
Directive: ask your provider which of those five properties matter for the area you want treated.
On adverse events, www.mdedge.com says:
Seven patients in the study reported adverse events, which were short term and minor, resolving within a month.
Directive: note that the report calls these events short term and minor, and ask your provider what to expect after treatment.
What the report leaves unsaid
The statements above give no age range and no total number of patients. Read them as a description of one group of patients, not a promise for every face.
The dermal filler overview at asds.net sits under the title Injectables and is a place to read the wider category.
Other readings
Two more sources are worth opening. The Nonsurgical Facelift overview at my.clevelandclinic.org widens the topic. The page at radiesse.com, titled Collagen Biostimulation, is the second.
Take the quotes to a consultation
Bring the three quoted statements to a consultation. Ask for each one to be explained in your own words before you decide.